Basic Study
Copyright ©The Author(s) 2022.
World J Biol Chem. Sep 27, 2022; 13(4): 72-82
Published online Sep 27, 2022. doi: 10.4331/wjbc.v13.i4.72
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Serum levels of interferon-gamma in the groups with and without acute graft-versus-host disease. aGvHD: Acute graft-versus-host disease; allo-HSCT: Allogeneic hematopoietic stem cell transplantation; IFN: Interferon; Pre-C: Before conditioning treatment; Post-C: After conditioning treatment.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Serum levels of interferon-gamma in the groups with and without infection. allo-HSCT: Allogeneic hematopoietic stem cell transplantation; IFN: Interferon; Pre-C: Before conditioning treatment; Post-C: After conditioning treatment.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Serum levels of interleukin-2 in patients* with the value above 0 at least once in the post-transplantation period. *None of these patients presented with aGvHD. “+”: Day of the occurrence of infection independent of its etiology; “•”: Day of the occurrence of mucositis. Allo-HSCT: Allogeneic hematopoietic stem cell transplantation; IL-2: Interleukin-2; Pre-C: Before conditioning treatment; Post-C: After conditioning treatment.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Mean levels of interferon-gamma before and after allogeneic hematopoietic stem cell transplantation in the four groups of patients. Allo-HSCT: Allogeneic hematopoietic stem cell transplantation; IFN: Interferon; Pre-C: Before conditioning treatment; Post-C: After conditioning treatment.